• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N-丁基脱氧野尻霉素介导的对人类免疫缺陷病毒进入的抑制作用与gp120脱落受损和gp41暴露相关。

N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure.

作者信息

Fischer P B, Karlsson G B, Dwek R A, Platt F M

机构信息

Department of Biochemistry, Glycobiology Institute, University of Oxford, United Kingdom.

出版信息

J Virol. 1996 Oct;70(10):7153-60. doi: 10.1128/JVI.70.10.7153-7160.1996.

DOI:10.1128/JVI.70.10.7153-7160.1996
PMID:8794362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC190768/
Abstract

The alpha-glucosidase inhibitor N-butyldeoxynojirimycin (NB-DNJ) is an inhibitor of human immunodeficiency virus (HIV) replication and HIV-induced syncytium formation in vitro. Although an NB-DNJ-mediated change in viral envelope N-glycan composition inhibits HIV entry at the level of post-CD4 binding, the exact mechanism of inhibition remains to be established. In this study we have examined the effects of NB-DNJ on virion envelope composition and CD4-induced gp120 shedding and gp41 exposure. Virion composition analysis revealed an NB-DNJ-mediated reduction of 15% in overall virion envelope glycoprotein content and a reduction of 26% in the proteolytic maturation of virion gp160. Taken together, these two effects resulted in a reduction of approximately 40% in virion gp120 content. CD4-induced shedding of gp120 from the surfaces of envelope-transfected Cos cells was undetectable when gp120 was expressed in the presence of NB-DNJ. Similarly, the shedding of virion-associated gp120 was reduced 7.4-fold. CD4-induced exposure of cryptic gp41 epitopes on the surfaces of HIV-expressing ACH-2 cells was also greatly impaired, and the exposure of virion-associated gp41 epitopes was reduced 4.0-fold. Finally, CD4-induced increases in the binding of antibodies to the V3 loop of ACH-2-cell-expressed envelope glycoproteins were reduced 25-fold when the glycoproteins were expressed in the presence of NB-DNJ. These results suggest that the NB-DNJ-mediated retention of glycosylated N-glycans inhibits HIV entry by a combined effect of a reduction in virion gp120 content and a qualitative defect within the remaining gp120, preventing it from undergoing conformational changes after CD4 binding.

摘要

α-葡萄糖苷酶抑制剂N-丁基脱氧野尻霉素(NB-DNJ)在体外是人类免疫缺陷病毒(HIV)复制及HIV诱导的合胞体形成的抑制剂。尽管NB-DNJ介导的病毒包膜N-聚糖组成变化在CD4结合后水平抑制HIV进入,但确切的抑制机制仍有待确定。在本研究中,我们检测了NB-DNJ对病毒粒子包膜组成以及CD4诱导的gp120脱落和gp41暴露的影响。病毒粒子组成分析显示,NB-DNJ介导病毒粒子包膜糖蛋白总含量降低15%,病毒粒子gp160的蛋白水解成熟降低26%。综合这两种效应,导致病毒粒子gp120含量降低约40%。当在NB-DNJ存在的情况下表达gp120时,在包膜转染的Cos细胞表面未检测到CD4诱导的gp120脱落。同样,病毒粒子相关gp120的脱落减少了7.4倍。在表达HIV的ACH-2细胞表面,CD4诱导的隐蔽gp41表位暴露也受到极大损害,病毒粒子相关gp41表位的暴露减少了4.0倍。最后,当在NB-DNJ存在的情况下表达糖蛋白时,CD4诱导的抗体与ACH-2细胞表达的包膜糖蛋白V3环结合增加减少了25倍。这些结果表明,NB-DNJ介导的糖基化N-聚糖保留通过降低病毒粒子gp120含量以及剩余gp120内的质量缺陷的联合效应抑制HIV进入,从而阻止其在CD4结合后发生构象变化。

相似文献

1
N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure.N-丁基脱氧野尻霉素介导的对人类免疫缺陷病毒进入的抑制作用与gp120脱落受损和gp41暴露相关。
J Virol. 1996 Oct;70(10):7153-60. doi: 10.1128/JVI.70.10.7153-7160.1996.
2
N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120.N-丁基脱氧野尻霉素介导的对人类免疫缺陷病毒进入的抑制作用与gp120的V1/V2区域抗体识别的变化相关。
J Virol. 1996 Oct;70(10):7143-52. doi: 10.1128/JVI.70.10.7143-7152.1996.
3
The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.α-葡萄糖苷酶抑制剂N-丁基脱氧野尻霉素在CD4结合后的水平上抑制人类免疫缺陷病毒的进入。
J Virol. 1995 Sep;69(9):5791-7. doi: 10.1128/JVI.69.9.5791-5797.1995.
4
Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events.可溶性CD4诱导的人类免疫缺陷病毒1型外膜糖蛋白脱落与随后的膜融合事件之间缺乏相关性。
J Virol. 1992 Sep;66(9):5516-24. doi: 10.1128/JVI.66.9.5516-5524.1992.
5
Effects of the imino sugar N-butyldeoxynojirimycin on the N-glycosylation of recombinant gp120.亚氨基糖N-丁基脱氧野尻霉素对重组糖蛋白120 N-糖基化的影响
J Biol Chem. 1993 Jan 5;268(1):570-6.
6
N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery.N-丁基脱氧野尻霉素是一种通过靶向脂质体递送显著增强疗效的广谱抗HIV疗法。
AIDS. 2008 Oct 1;22(15):1961-9. doi: 10.1097/QAD.0b013e32830efd96.
7
Strain-Dependent Activation and Inhibition of Human Immunodeficiency Virus Entry by a Specific PF-68742 Stereoisomer.特定 PF-68742 立体异构体对人类免疫缺陷病毒进入的应变依赖性激活和抑制。
J Virol. 2019 Oct 15;93(21). doi: 10.1128/JVI.01197-19. Print 2019 Nov 1.
8
The Polar Region of the HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing the gp120-gp41 Association.HIV-1 包膜蛋白的极地区域通过稳定 gp120-gp41 相互作用来决定病毒融合和感染性。
J Virol. 2019 Mar 21;93(7). doi: 10.1128/JVI.02128-18. Print 2019 Apr 1.
9
HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.HIV-1 gp41 残基调节包膜糖蛋白中 CD4 诱导的构象变化和 gp120 构象的弛豫演化。
J Virol. 2018 Jul 31;92(16). doi: 10.1128/JVI.00583-18. Print 2018 Aug 15.
10
Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.CD4模拟化合物对原代人免疫缺陷病毒包膜糖蛋白三聚体的激活与失活作用
J Virol. 2017 Jan 18;91(3). doi: 10.1128/JVI.01880-16. Print 2017 Feb 1.

引用本文的文献

1
Expanding horizons of iminosugars as broad-spectrum anti-virals: mechanism, efficacy and novel developments.亚氨基糖作为广谱抗病毒药物的视野拓展:作用机制、疗效及新进展
Nat Prod Bioprospect. 2024 Sep 26;14(1):55. doi: 10.1007/s13659-024-00477-5.
2
Antiviral activity of glucosylceramide synthase inhibitors in alphavirus infection of the central nervous system.葡萄糖神经酰胺合酶抑制剂在甲病毒感染中枢神经系统中的抗病毒活性。
Brain Commun. 2023 Mar 25;5(3):fcad086. doi: 10.1093/braincomms/fcad086. eCollection 2023.
3
An Amination-Cyclization Cascade Reaction for Iminosugar Synthesis Using Minimal Protecting Groups.一种使用最少保护基团的亚氨基糖合成的胺化-环化串联反应。
ACS Omega. 2022 Aug 10;7(33):28756-28766. doi: 10.1021/acsomega.1c01646. eCollection 2022 Aug 23.
4
Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus.葡萄糖神经酰胺合成酶抑制剂可预防 SARS-CoV-2 和流感病毒的复制。
J Biol Chem. 2021 Jan-Jun;296:100470. doi: 10.1016/j.jbc.2021.100470. Epub 2021 Feb 25.
5
Discovery of Novel Coumarin Analogs against the α-Glucosidase Protein Target of Diabetes Mellitus: Pharmacophore-Based QSAR, Docking, and Molecular Dynamics Simulation Studies.新型香豆素类似物针对糖尿病α-葡萄糖苷酶蛋白靶点的发现:基于药效团的定量构效关系、对接及分子动力学模拟研究
ACS Omega. 2020 Dec 10;5(50):32234-32249. doi: 10.1021/acsomega.0c03871. eCollection 2020 Dec 22.
6
N-Glycan Modification in Covid-19 Pathophysiology: In vitro Structural Changes with Limited Functional Effects.新冠病毒病理生理学中的 N-聚糖修饰:体外结构变化有限,功能影响不大。
J Clin Immunol. 2021 Feb;41(2):335-344. doi: 10.1007/s10875-020-00905-4. Epub 2020 Nov 27.
7
Iminosugars: A host-targeted approach to combat Flaviviridae infections.亚氨基糖:针对黄病毒科感染的宿主靶向治疗方法。
Antiviral Res. 2020 Dec;184:104881. doi: 10.1016/j.antiviral.2020.104881. Epub 2020 Aug 5.
8
Genetic diseases conferring resistance to infectious diseases.赋予对传染病抵抗力的遗传疾病。
Genes Dis. 2015 Feb 25;2(3):247-254. doi: 10.1016/j.gendis.2015.02.008. eCollection 2015 Sep.
9
Iminosugars: Promising therapeutics for influenza infection.亚氨基糖:流感感染的有前景的治疗药物。
Crit Rev Microbiol. 2017 Sep;43(5):521-545. doi: 10.1080/1040841X.2016.1242868. Epub 2016 Dec 8.
10
Minimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig Model.氨基糖在致死性埃博拉病毒豚鼠模型中的体内最小疗效
PLoS One. 2016 Nov 23;11(11):e0167018. doi: 10.1371/journal.pone.0167018. eCollection 2016.

本文引用的文献

1
Increased envelope spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses.原发性人类免疫缺陷病毒的中和抗性并不需要增加包膜刺突密度和稳定性。
J Virol. 1996 Sep;70(9):6136-42. doi: 10.1128/JVI.70.9.6136-6142.1996.
2
Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120.CD4介导的1型人类免疫缺陷病毒gp120合胞体形成及脱落的物理化学解离
J Virol. 1993 Jul;67(7):3818-25. doi: 10.1128/JVI.67.7.3818-3825.1993.
3
Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody.人类免疫缺陷病毒1型gp120糖蛋白V1/V2区域氨基酸变化对亚基缔合、合胞体形成及中和抗体识别的影响。
J Virol. 1993 Jun;67(6):3674-9. doi: 10.1128/JVI.67.6.3674-3679.1993.
4
Two mechanisms of soluble CD4 (sCD4)-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) infectivity and their relation to primary HIV-1 isolates with reduced sensitivity to sCD4.可溶性CD4(sCD4)介导的对1型人类免疫缺陷病毒(HIV-1)感染性的抑制作用的两种机制及其与对sCD4敏感性降低的原发性HIV-1分离株的关系。
J Virol. 1993 Mar;67(3):1461-71. doi: 10.1128/JVI.67.3.1461-1471.1993.
5
Effects of the imino sugar N-butyldeoxynojirimycin on the N-glycosylation of recombinant gp120.亚氨基糖N-丁基脱氧野尻霉素对重组糖蛋白120 N-糖基化的影响
J Biol Chem. 1993 Jan 5;268(1):570-6.
6
Mechanism of action of N-butyl deoxynojirimycin in inhibiting HIV-1 infection and activity in combination with nucleoside analogs.
AIDS Res Hum Retroviruses. 1993 Apr;9(4):291-7. doi: 10.1089/aid.1993.9.291.
7
Receptor-mediated activation of the viral envelope and viral entry.
AIDS. 1993;7 Suppl 1:S43-50.
8
Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions.1型人类免疫缺陷病毒包膜糖蛋白主要可变区缺失的功能和免疫学特征
J Virol. 1993 Aug;67(8):4557-65. doi: 10.1128/JVI.67.8.4557-4565.1993.
9
Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120.人类免疫缺陷病毒1型包膜糖蛋白gp120的V1/V2和C4结构域之间功能相互作用的证据。
J Virol. 1994 Apr;68(4):2503-12. doi: 10.1128/JVI.68.4.2503-2512.1994.
10
Inhibition of alpha-glucosidase I of the glycoprotein-processing enzymes by 6-O-butanoyl castanospermine (MDL 28,574) and its consequences in human immunodeficiency virus-infected T cells.6-O-丁酰栗精胺(MDL 28,574)对糖蛋白加工酶α-葡糖苷酶I的抑制作用及其在人类免疫缺陷病毒感染的T细胞中的后果。
Antimicrob Agents Chemother. 1994 Aug;38(8):1780-7. doi: 10.1128/AAC.38.8.1780.